AGP Executive Report
Last update: 2 hours agoRespiratory Care: Philips launched a home oxygen concentrator in India for people needing long-term oxygen therapy, as chronic respiratory disease remains a major health burden. Affordable Diagnostics: Maharashtra set prices for PET-CT scans and CT/MRI contrast at government hospitals, with free tests for eligible low-income patients. Autoimmune Research: ICMR is funding a four-year study of 200 families to investigate genetic and immune links to autoimmune diseases and identify potential treatment targets. Peptide Policy: HHS will temporarily let compounding pharmacies supply six unapproved peptides under enforcement discretion; the move does not establish that the products are safe or effective. Drug Costs: A new Labor Department rule will require pharmacy benefit managers to disclose payments and rebates to employer health plans, with the aim of improving transparency and lowering costs. Heart Care: Abbott won FDA approval for a catheter-delivered device to close leaks around replacement heart valves, offering some patients an alternative to repeat open-heart surgery. Coverage Pressures: Michigan approved average 2027 health-insurance rate increases of 14.2% for individual plans and 9.6% for small-group plans, while marketplace enrollment has fallen sharply.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
